Entheon Biomedical | Company Profile
CSE: ENBI
Latest Sector Updates
Entheon is pioneering an addiction recovery solution that harnesses the therapeutic potential of the DMT molecule. They are developing a DMT-assisted scalable therapeutic protocol for substance abuse disorder.
Entheon listed on the CSE in November 2020 and announced a private placement in December 2020 raising just over C$3.2m.
.
Stock information
Contact Information
Website: https://entheonbiomedical.com/
Contact Email: Joe@entheonbiomedical.com (Joseph Cullen, Investor Relations)
Corporate Presentation Link: not available
Latest Entheon News
Entheon Biomedical Provides Corporate Update on Studies and Clinical Trials
Vancouver, British Columbia–(Newsfile Corp. – October 27, 2021) – Entheon Biomedical Corp. (CSE: ENBI) (OTCQB: ENTBF) (FSE: 1XU1) (” Entheon ” or the ” Company “), a biotechnology company ...
Clinical Director of Imperial College’s Center for Psychedelic Research Joins Entheon Advisory Board
Vancouver, British Columbia–(Newsfile Corp. – August 25, 2021) – Entheon Biomedical Corp. (CSE: ENBI) (OTCQB: ENTBF) (FSE: 1XU1) (” Entheon ” or the ” Company “), a biotechnology company ...
Clinical Director of Imperial College’s Center for Psychedelic Research Joins Entheon Advisory Board
Vancouver, British Columbia–(Newsfile Corp. – August 25, 2021) – Entheon Biomedical Corp. (CSE: ENBI) (OTCQB: ENTBF) (FSE: 1XU1) (” Entheon ” or the ” Company “), a biotechnology company ...
Entheon Biomedical Corp. Announces DTC Eligibility
Vancouver, British Columbia–(Newsfile Corp. – August 24, 2021) – Entheon Biomedical Corp. (CSE: ENBI) (OTCQB: ENTBF) (FSE: 1XU1) (” Entheon ” or the ” Company “), a biotechnology company ...
Entheon Biomedical Announces Sponsorship of a Clinical Study to Assess the Electroneurophysiologic Effects of Ketamine
Vancouver, British Columbia–(Newsfile Corp. – August 12, 2021) – Entheon Biomedical Corp. (CNSX:ENBI.CN) (OTCQB:ENTBF) (FSE:1XU1) (” Entheon ” or the ” Company “), a biotechnology company focused on developing ...
Entheon Biomedical Corp. Acquires Lobo Genetics Inc.
Vancouver, British Columbia–(Newsfile Corp. – July 30, 2021) – Entheon Biomedical Corp. (CNSX:ENBI.CN) (OTCQB:ENTBF) (FSE:1XU1) (” Entheon ” or the ” Company “) is pleased to announce that the ...
